Zhejiang East Asia Pharmaceutical Co., Ltd. (SHA:605177)
China flag China · Delayed Price · Currency is CNY
21.72
+0.19 (0.88%)
Feb 13, 2026, 3:00 PM CST

SHA:605177 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
2,4452,2183,0082,2743,1404,033
Market Cap Growth
24.65%-26.27%32.27%-27.57%-22.14%-
Enterprise Value
3,0592,6812,7321,9022,5043,866
Last Close Price
21.7219.7026.0819.4826.6433.87
PE Ratio
--24.8121.7845.8435.23
Forward PE
-10.1518.20---
PS Ratio
2.941.852.221.934.414.57
PB Ratio
1.351.181.491.241.792.33
P/TBV Ratio
1.391.221.541.281.832.40
P/FCF Ratio
-----46.99
P/OCF Ratio
-----27.45
EV/Sales Ratio
3.682.242.011.613.524.39
EV/EBITDA Ratio
-123.5912.4110.5324.5621.55
EV/EBIT Ratio
--24.4321.4976.3733.21
EV/FCF Ratio
-7.45----45.05
Debt / Equity Ratio
0.550.420.350.070.000.01
Debt / EBITDA Ratio
-30.463.150.670.020.06
Debt / FCF Ratio
-----0.12
Net Debt / Equity Ratio
0.340.12-0.09-0.22-0.34-0.57
Net Debt / EBITDA Ratio
-10.4410.60-0.83-2.26-5.92-5.46
Net Debt / FCF Ratio
-1.50-0.620.592.594.15-11.41
Asset Turnover
0.240.350.470.500.330.55
Inventory Turnover
1.041.501.832.031.522.11
Quick Ratio
0.640.821.581.221.643.52
Current Ratio
1.661.672.502.092.614.41
Return on Equity (ROE)
-11.39%-5.18%6.29%5.80%3.93%8.88%
Return on Assets (ROA)
-3.76%-1.99%2.40%2.34%0.95%4.56%
Return on Invested Capital (ROIC)
-8.70%-5.58%6.17%6.21%3.06%13.79%
Return on Capital Employed (ROCE)
-7.90%-4.20%4.20%4.70%1.80%6.60%
Earnings Yield
-8.93%-4.54%4.03%4.59%2.18%2.84%
FCF Yield
-16.79%-16.60%-10.36%-6.96%-4.64%2.13%
Dividend Yield
--1.25%1.49%0.75%1.03%
Payout Ratio
--29.90%22.37%57.00%16.11%
Buyback Yield / Dilution
21.23%10.52%-10.13%0.57%-30.62%-2.79%
Total Shareholder Return
21.23%10.52%-8.87%2.06%-29.87%-1.76%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.